Join the club for FREE to access the whole archive and other member benefits.

Qihan Biotech

Company that uses genome editing technologies to deliver regenerative medicine solutions

Qihan Biotech is a biotechnology company applying genome-editing technology to develop novel cell therapies and organs for transplantation. The company’s mission is to use high-throughput, multiplexable genome editing in combination with expertise in transplantation immunology to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other important medical conditions. With a vision to create a world in which cell and organ therapies are universally available to patients, Qihan Biotech has raised three rounds of financing and is advancing its cell therapy programs into IND-enabling investigations.

Visit website:


Details last updated 01-Oct-2021

People at Qihan Biotech

Luhan Yang

Founder& CEO of Qihan Biotech

Topics mentioned on this page:
Gene Therapy, Regenerative Medicine